[ Price : $8.95]
Regeneron says it will submit an odronexamab trial protocol amendment to FDA in hopes of resuming trial enrollments in 2021.[ Price : $8.95]
Attorneys Dick Dean and Emmanuel Sanders see the possibility that five Supreme Court justices would vote to overturn Wyeth v. Levi...[ Price : $8.95]
FDA approves an Athenex NDA for Klisyri (tirbanibulin) for the topical treatment of actinic keratosis on the face or scalp.[ Price : $8.95]
FDA grants Spark Biomedical a Breakthrough Device Designation for the Roo System: a transcutaneous electrical nerve stimulator tha...[ Price : $8.95]
Some 20 Senate Democrats ask Operation Warp Speed leaders for answers to questions about the governments decision not to exercise ...[ Price : $8.95]
Mesoblast says its rexlemestrocel-L reduced cardiac mortality in a Phase 3 trial of patients with advanced chronic heart failure.[ Price : $8.95]
The ACLU again criticizes the Trump administration and FDA for requiring patients seeking access to the abortion pill to go to a h...[ Price : $8.95]
FDA releases its latest batch of Warning Letters that include JC Ayur Life and Desert Alchemist.